Scottish researchers have developed a technique designed to reduce the need for islet cell transplant donors, which in turn may help improve procedure wait times for those with type 1 diabetes. In the procedure, an initial transplant is provided from one donor and some of the donated cells are used to generate more beta cells that are given to the patient in a second transplant.

Related Summaries